Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fizurex
- Development stage
- Preclinical
- Lead developer
- Steel Therapeutics
- Modality
- Hydrogel Systems → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Administration
- Topical
01
Overview
Fizurex is a **patent-pending, single-use, disposable wipe** intended as a more convenient, consistent, and patient-friendly formulation of a **combination therapy containing nifedipine and lidocaine**, designed for the treatment of **anal fissures**. This combination has been widely compounded and used off-label in cream formulations, where it is thought to work by **increasing blood flow and relaxing the anal sphincter**, thereby promoting healing. Fizurex aims to bring this established therapy to a wider population in a regulated, GMP-compliant, and standardized format suitable for FDA approval. The product is currently in preclinical development and preparing for Investigational New Drug (IND) submission, with planned progression to clinical trials[1][3][4][5][7][8].
- Brand names
- Fizurex
02
Targets
NaV (Voltage-gated sodium channels)CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)
Beyond the preview
Go deeper on Fizurex.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fizurex.